Morgan Stanley’s Cerence CRNC Stock Holding History
Bought
Maintained
Sold
Other funds holding CRNC
OFCM
Morgan Stanley's CRNC Position: Q3 2026 in Review
Morgan Stanley reduced its Cerence (CRNC) stake by 29% in Q3 2026, selling an estimated $1.8M and leaving 511,026 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #4426.
Morgan Stanley first reported a position in CRNC in Q4 2019 and has held it in 28 quarters since. The position peaked at $35.8M in Q2 2021. 191 funds tracked by Wall St. Rank hold CRNC as of Q3 2026.
- Morgan Stanley held 511,026 shares of Cerence worth $4M as of Q3 2026.
- Morgan Stanley sold 205,643 Cerence shares in Q3 2026, an estimated $1.8M.
- Cerence made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #4426 holding.
- Morgan Stanley first reported a position in Cerence in Q4 2019 and has held it in 28 quarters since.
- Morgan Stanley's Cerence position peaked at $35.8M in Q2 2021.
- 191 funds tracked by Wall St. Rank held Cerence as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.